Terms: = Breast cancer AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC
159 results:
1. Secretory Carcinoma with ETV6-ntrk3 Gene Fusion and Lymph Node Metastasis in Maxillary Gingiva: A Case Report with Pathological and Molecular Correlative Studies.
Fujita J; Krishnan B; Green LK; Sandulache VC; Lai S
Ann Clin Lab Sci; 2023 Sep; 53(5):800-805. PubMed ID: 37945013
[TBL] [Abstract] [Full Text] [Related]
2. Utility of MUC4 in the diagnosis of secretory carcinoma of salivary glands.
Fatima S; Ahmed A; Suleman S; Din NU
Ann Diagn Pathol; 2023 Dec; 67():152220. PubMed ID: 37924657
[TBL] [Abstract] [Full Text] [Related]
3. Salivary Gland Secretory Carcinoma; Review of 13 Years World-Wide Experience and Meta-Analysis.
Yosefof E; Boldes T; Dan D; Robenshtok E; Strenov Y; Bachar G; Shpitzer T; Mizrachi A
Laryngoscope; 2024 Apr; 134(4):1716-1724. PubMed ID: 37909690
[TBL] [Abstract] [Full Text] [Related]
4. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
Zhao YY; Ge HJ; Yang WT; Shao ZM; Hao S
Breast Cancer Res Treat; 2024 Feb; 203(3):543-551. PubMed ID: 37897648
[TBL] [Abstract] [Full Text] [Related]
5. A case report and literature review on a rare subtype of triple-negative breast cancer in children.
Shi L; Zhang Y; Wu J; Li J; Zhu J; Xu Y; Li N; Li Q; Zhang W
BMC Pediatr; 2023 Sep; 23(1):494. PubMed ID: 37773118
[TBL] [Abstract] [Full Text] [Related]
6. Secretory carcinoma of salivary glands with ntrk3 break-apart molecular rearrangement: Potential misdiagnosis with mucoepidermoid carcinoma.
Nocini R; Sanna G; Trotolo A; Fior A; Brunelli M; Manfrin E; Favero V
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101635. PubMed ID: 37709146
[TBL] [Abstract] [Full Text] [Related]
7. Secretory breast cancer in a boy: A case report with genetic analysis using next-generation sequencing and literature review.
Deng L; Li Y; Zhong J
Medicine (Baltimore); 2023 Jul; 102(27):e34192. PubMed ID: 37417596
[TBL] [Abstract] [Full Text] [Related]
8. High-grade non-intestinal type sinonasal adenocarcinoma with ETV6::ntrk3 fusion, distinct from secretory carcinoma by immunoprofile and morphology.
Klubíčková N; Mosaieby E; Ptáková N; Trinquet A; Laé M; Costes-Martineau V; Skálová A
Virchows Arch; 2023 Aug; 483(2):187-195. PubMed ID: 37415052
[TBL] [Abstract] [Full Text] [Related]
9. NTRK fusions in solid tumours: what every pathologist needs to know.
Nguyen MA; Colebatch AJ; Van Beek D; Tierney G; Gupta R; Cooper WA
Pathology; 2023 Aug; 55(5):596-609. PubMed ID: 37330338
[TBL] [Abstract] [Full Text] [Related]
10. NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS.
Zito Marino F; Buono S; Montella M; Giannatiempo R; Messina F; Casaretta G; Arpino G; Vita G; Fiorentino F; Insabato L; Sgambato A; Orditura M; Franco R; Accardo M
J Pathol Clin Res; 2023 Sep; 9(5):367-377. PubMed ID: 37143440
[TBL] [Abstract] [Full Text] [Related]
11. Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System.
Baněčková M; Thompson LDR; Hyrcza MD; Vaněček T; Agaimy A; Laco J; Simpson RHW; Di Palma S; Stevens TM; Brcic L; Etebarian A; Dimnik K; Majewska H; Stárek I; O'Regan E; Salviato T; Helliwell T; Horáková M; Biernat W; Onyuma T; Michal M; Leivo I; Skalova A
Am J Surg Pathol; 2023 Jun; 47(6):661-677. PubMed ID: 37070739
[TBL] [Abstract] [Full Text] [Related]
12. Real-world experience of tropomyosin receptor kinase inhibition with entrectinib in ETV6-ntrk3 positive metastatic salivary secretory carcinoma: A case series.
Yokota T; Yukino H; Doi M; Ohori H
Head Neck; 2023 May; 45(5):E10-E15. PubMed ID: 36924196
[TBL] [Abstract] [Full Text] [Related]
13. Approaches to the diagnosis of secretory carcinoma of the salivary glands: a case series and review.
Hermann CR; Gama-Cuellar AG; Díaz KP; Gondak R
Gen Dent; 2023; 71(2):23-27. PubMed ID: 36825969
[TBL] [Abstract] [Full Text] [Related]
14. A challenging diagnosis of mammary analogue secretory carcinoma (MASC) on fine needle aspiration cytology and cell block: A cytopathologist's perspective.
Saraf P; Bharti JN; Malik A
Cytopathology; 2023 Jul; 34(4):377-380. PubMed ID: 36825352
[TBL] [Abstract] [Full Text] [Related]
15. Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitors.
Lassche G; van Engen-van Grunsven ACH; van Hooij O; Aalders TW; Am Weijers J; Cocco E; Drilon A; Hoischen A; Neveling K; Schalken JA; Verhaegh GW; van Herpen CML
Oral Oncol; 2023 Feb; 137():106297. PubMed ID: 36610231
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features.
Lei T; Yang Y; Shi Y; Deng X; Peng Y; Wang H; Chen T
Diagn Pathol; 2022 Dec; 17(1):101. PubMed ID: 36585729
[TBL] [Abstract] [Full Text] [Related]
17. Sentinel lymph node biopsy in women over 70: Evaluation of rates of axillary staging and impact on adjuvant therapy in elderly women.
Di Lena É; Antoun A; Hopkins B; Barone N; Do U; Meterissian S
Surgery; 2023 Mar; 173(3):603-611. PubMed ID: 36372577
[TBL] [Abstract] [Full Text] [Related]
18. Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis.
Han M; Wang Y; Jin Y; Zhao X; Cui H; Wang G; Gang X
Front Endocrinol (Lausanne); 2022; 13():984593. PubMed ID: 36313770
[TBL] [Abstract] [Full Text] [Related]
19. Secretory carcinoma of the sinonasal cavity and pharynx: A retrospective analysis of four cases and literature review.
Yue C; Zhao X; Ma D; Piao Y
Ann Diagn Pathol; 2022 Dec; 61():152052. PubMed ID: 36270241
[TBL] [Abstract] [Full Text] [Related]
20. Metastatic triple negative breast cancer with NTRK gene fusion on tissue but not on ctDNA molecular profile.
Singh N; Singh R; Decker B; Robins D; Vidal G
BMJ Case Rep; 2022 Oct; 15(10):. PubMed ID: 36223973
[TBL] [Abstract] [Full Text] [Related]
[Next]
